Beta Bionics, Inc.
BBNX
$17.46
$0.422.47%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -63.63M | -- | -- | -- | |
| Total Depreciation and Amortization | 1.79M | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 25.21M | -- | -- | -- | |
| Change in Net Operating Assets | -11.21M | -- | -- | -- | |
| Cash from Operations | -47.85M | -- | -- | -- | |
| Capital Expenditure | -2.67M | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | 0.00 | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -199.94M | -- | -- | -- | |
| Cash from Investing | -202.61M | -- | -- | -- | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 211.20M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | 59.66M | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -2.81M | -- | -- | -- | |
| Cash from Financing | 268.05M | -- | -- | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 17.59M | -- | -- | -- | |